SUN PHARMA (SUNPHARMA) - Live BSE, NSE Stock Quotes - SUN PHARMA Analysis Update - Equitymaster.com
X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2016 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUN PHARMA   (SUNP)

REFRESH
Live BSE Quotes Sep 23, 2016 (Close)
Price (Rs)780.10 Open (Rs) 790.00 High (Rs) 792.20 Low (Rs) 778.00
% Change-0.81 Volume 238,625 Value (Rs) 187,753,090 52-Week H/L 933.70 / 706.40
Live NSE Quotes Sep 23, 2016 (Close)
Price (Rs)780.05 Open (Rs) 790.10 High (Rs) 790.75 Low (Rs) 778.00
% Change-0.85 Volume 1,768,021 Value (Rs) 1,388,236,548 52-Week H/L 933.95 / 704.00
Valuation
EPS (Rs)* 30.28 P/E Ratio (x) 25.77 Market Cap (Rs m) 1,615,711.92 P/BV (x) 5.14
  *Trailing 12 months earnings, excluding extraordinary / exceptional items. BSE Sensex | CNX Nifty

Charts
SUN PHARMA Stock Price Chart (Rs) - 1 Year
Loading...
 
Peer Group:
Quote & Graph
     
 S&P BSE SENSEX 
PERIOD
Advanced Charts new

Related Views On News

Sun Pharma: US Segment Shows Signs of Improvement (Quarterly Results Update - Detailed)

Sep 12, 2016

Sun Pharma has announced its 1QFY17 results. The company has reported 22.7% YoY growth in sales and a growth of 266% in the net profits. Here is our analysis of the results.

Sun Pharma: Acquisition synergies start contributing (Quarterly Results Update - Detailed)

Apr 1, 2016

Sun Pharma has announced its 3QFY16 results. Net sales have grown by 2.3% YoY, while net profits surged by 258% YoY. Here is our analysis of the results.

Sun Pharma: Regulatory issues get more serious (Quarterly Results Update - Detailed)

Nov 17, 2015

Sun Pharma has announced its 2QFY16 results. The company has reported a 14.7% YoY decline in the topline, while net profits plummeted by 46% YoY. Here is our analysis of the results.

Biocon: Lower R&D Expenses Help Margin Expansion (Quarterly Results Update - Detailed)

Sep 19, 2016

Biocon has announced its 1QFY17. The company has reported 21.1% YoY growth in total income and 34.6% YoY increase in net profits. Here is our analysis of the results.

Cipla: Weak Quarter, Positive Triggers Ahead (Quarterly Results Update - Detailed)

Sep 19, 2016

Cipla has announced its results for the June quarter (1QFY17) results. The company has reported a decline of 6.4% YoY in sales while profits were down by 43.7% YoY.

More Views on News

Most Popular

Jaitley's New Real Estate Pipe Dream: Where Rents Equal EMIs(Vivek Kaul's Diary)

Sep 13, 2016

The finance minister at a recent conference got nostalgic about the Vajpayee era when rents were fairly close to EMIs.

Here's One More Reason to Believe in Sensex 40,000(The 5 Minute Wrapup)

Sep 14, 2016

Strong faith of foreign promoters in the Indian economy cements our long-term view on the Sensex.

Which Tata Company has done the best under Cyrus Mistry?(Chart Of The Day)

Sep 15, 2016

Voltas and Tata Communications top performers under Cyrus Mistry.

What is Open Interest?(Daily Profit Hunter)

Sep 14, 2016

Apurva Sheth talks about the sixth primary data point in futures and options market - Open Interest.

Should You Worry About How Much Your Fund Manager Earns?(Outside View)

Sep 19, 2016

PersonalFN explains why instead of focusing merely on how much your fund manager earns, a holistic assessment is imperative to select mutual funds prudently for your investment portfolio.

More

TRACK SUN PHARMA

  • Track your investment in SUN PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SUN PHARMA - TTK HEALTHCARE COMPARISON

Compare Company With Charts

COMPARE SUN PHARMA WITH

MARKET STATS